The analysis of The Cancer Genome Atlas (TCGA) data demonstrated that genetic alterations in the epidermal growth factor receptor (EGFR) are the most frequent receptor tyrosine kinase (RTK) lesions in primary glioblastoma, occurring overall in 57% of these tumors [53]. This evidence concerns the gene EGFR and glioblastoma.